PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DEL ANTÍGENO CANCERÍGENO 19-9 (CA 19-9) EN MUESTRAS DE SANGRE ENTERA, SUERO O PLASMA - COFEPRIS Registration 1480R2024 SSA

Access comprehensive regulatory information for PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DEL ANTÍGENO CANCERÍGENO 19-9 (CA 19-9) EN MUESTRAS DE SANGRE ENTERA, SUERO O PLASMA (PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DEL ANTÍGENO CANCERÍGENO 19-9 (CA 19-9) EN MUESTRAS DE SANGRE ENTERA, SUERO O PLASMA) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1480R2024 SSA and manufactured by CORPORINTER, S.A. DE C.V.. The device was registered on May 21, 2024.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.